Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/23393
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Memmert, U | - |
dc.contributor.author | Peither, A | - |
dc.contributor.author | Burri, R | - |
dc.contributor.author | Weber, K | - |
dc.contributor.author | Schmidt, T | - |
dc.contributor.author | Sumpter, JP | - |
dc.contributor.author | Hartmann, A | - |
dc.date.accessioned | 2021-10-27T10:24:20Z | - |
dc.date.available | 2013-02-01 | - |
dc.date.available | 2021-10-27T10:24:20Z | - |
dc.date.issued | 2013-01-16 | - |
dc.identifier.citation | Memmert, U., Peither, A., Burri, R., Weber, K., Schmidt, T., Sumpter, J. P. and Hartmann, A. (2013) 'Diclofenac: New data on chronic toxicity and bioconcentration in fish', Environmental Toxicology and Chemistry, 2013, 32 (2), pp. 442 - 452. doi: 10.1002/etc.2085. | en_US |
dc.identifier.issn | 0730-7268 | - |
dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/23393 | - |
dc.description.abstract | Diclofenac (DCF) is a widely used nonsteroidal anti-inflammatory drug that is regularly detected in surface waters. To support a robust aquatic risk assessment, two early life stage (ELS) tests, compliant with the Organisation for Economic Co-operation and Development (OECD) test guideline 210, were conducted in rainbow trout and in zebrafish. Population relevant endpoints, such as hatching, growth, and survival, and in the trout study, histopathological effects in potential target organs, were examined. The bioconcentration of DCF in rainbow trout was measured in a separate study according to OECD test guideline 305. The bioconcentration factor (BCF) in rainbow trout remained below 10, demonstrating no relevant bioconcentration of DCF in fish. In the rainbow trout ELS test, the no observed effect concentration (NOEC) including histopathology was 320μg/L. The effect of DCF on zebrafish growth was less clear, and the NOEC can be interpreted as 10μg/L. However, for a number of reasons, the authors consider the moderately reduced growth of zebrafish exposed to concentrations of up to 320μg/L not a repeatable, treatment-related effect of DCF. This leads us to a conclusion that DCF has, with high probability, no adverse effect on both fish species up to 320μg/L. This NOEC indicates a sufficient safety margin for fish populations, because concentrations of DCF in European rivers are in the range of ng/L to low μg/L. © 2013 SETAC. | en_US |
dc.description.sponsorship | Novartis International AG, Switzerland. | en_US |
dc.format.extent | 442 - 452 | - |
dc.format.medium | Print-Electronic | - |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley on behalf of SETAC | en_US |
dc.rights | Copyright © 2013 SETAC, Open Access under a Creative Commons Attribution licence. | - |
dc.subject | diclofenac | en_US |
dc.subject | NSAID | en_US |
dc.subject | fish toxicity | en_US |
dc.subject | fish early life stage | en_US |
dc.subject | bioconcentration | en_US |
dc.title | Diclofenac: New data on chronic toxicity and bioconcentration in fish | en_US |
dc.type | Article | en_US |
dc.identifier.doi | https://doi.org/10.1002/etc.2085 | - |
dc.relation.isPartOf | Environmental Toxicology and Chemistry | - |
pubs.issue | 2 | - |
pubs.publication-status | Published | - |
pubs.volume | 32 | - |
dc.identifier.eissn | 1552-8618 | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 193.12 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.